Chondrogenic differentiation by mesenchymal progenitor cells (MPCs) is associated with cytokines such as transforming growth factor-beta 1 (TGF-PI) and dexamethasone. Extracellular matrix (ECM) also regulates the differentiation by MPCs. To define whether ECM plays a functional role in regulation of the chondrogenic differentiation by MPCs, an in vitro model was used. That model exposed to dexamethasone, recombinant human TGF-@l(rhTGF-@I) and collagens. The results showed that MPCs incorporated with dexamethasone and rhTGF-01 increased proliferation and expression of glycosaminoglycan (GAG) after 14 days. Type 11 collagen enhanced the GAG synthesis, but did not increase alkaline phosphatase (ALP) activity. When adding dexamethasone and rhTGF-PI MPCs increased mRNA expression of sox9. Incorporation with type I1 collagen, dexamethasone and rhTGF-Pl, MPCs induced mRNA expression of aggrecan and enhanced levels of type I1 collagen, and sox9 mRNA. In contrast, incorporation with type I collagen, dexamethasone and rhTGF-PI MPCs reduced levels of aggrecan, and sox9 mRNA, and showed no type I1 collagen mRNA. Altogether, these results indicate that type I and I1 collagen, in addition to the cytokine effect, may play a functional role in regulating of chondrogenic differentiation by MPCs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.